| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,543 |
4,932 |
$1.07M |
| J0490 |
Injection, belimumab, 10 mg |
514 |
411 |
$689K |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
900 |
885 |
$567K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,445 |
33,235 |
$524K |
| J3262 |
Injection, tocilizumab, 1 mg |
454 |
387 |
$487K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,832 |
2,436 |
$448K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,757 |
1,448 |
$291K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,333 |
4,063 |
$245K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
904 |
852 |
$164K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
163 |
143 |
$132K |
| 96415 |
|
2,778 |
2,391 |
$105K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,737 |
4,698 |
$79K |
| Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
184 |
169 |
$57K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,272 |
973 |
$54K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,823 |
1,669 |
$33K |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
54 |
52 |
$16K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,240 |
1,147 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
661 |
619 |
$14K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
839 |
651 |
$11K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
14 |
13 |
$8K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
114 |
113 |
$793.62 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
219 |
181 |
$659.10 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
322 |
231 |
$647.93 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
162 |
106 |
$286.81 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
13 |
$0.00 |